Recon: EMA reviewing data on Pfizer booster shot; Roche, Adaptimmune sign $3B deal for off-the-shelf cell therapies
ReconMichael Mezher
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy